Geijsen, Anne J. M. R.
Kok, Dieuwertje E.
van Zutphen, Moniek
Keski-Rahkonen, Pekka
Achaintre, David
Gicquiau, Audrey
Gsur, Andrea
Kruyt, Flip M.
Ulrich, Cornelia M.
Weijenberg, Matty P.
de Wilt, Johannes H. W .
Wesselink, Evertine
Scalbert, Augustin
Kampman, Ellen
van Duijnhoven, Fränzel J. B. http://orcid.org/0000-0001-8367-2352
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cohort profile: Biomarkers related to folate-dependent one-carbon metabolism in colorectal cancer recurrence and survival – the FOCUS Consortium
https://doi.org/10.1136/bmjopen-2022-062930
Diet quality indices and dietary patterns are associated with plasma metabolites in colorectal cancer patients
https://doi.org/10.1007/s00394-021-02488-1
Pre- and post-diagnostic dairy intake in relation to recurrence and all-cause mortality in people with stage I-III colorectal cancer
https://doi.org/10.1007/s00394-023-03201-0
Funding for this research was provided by:
World Cancer Research Fund International (2014/1179)
KWF Kankerbestrijding (UM 2012-5653, UW 2013-5927, UW 2015-7946, UW2013-6397, UW2014-6877)
ZonMw
ERA-NET
Institut National du Cancer (INCA) (2014-007)
Foundation for the National Institutes of Health (U01 CA206110, R01 CA 189184, R01 CA207371)
Article History
Received: 8 May 2020
Accepted: 8 January 2021
First Online: 5 February 2021
Compliance with ethical standards
:
: Cornelia M. Ulrich (Director of the Comprehensive Cancer Center at Huntsman Cancer Institute, Salt Lake City, U.S.) oversees research funded by several pharmaceutical companies but has not received funding directly herself that could constitute a conflict to the current work. Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organization.
: The study was performed in accordance with the Declaration of Helsinki. The COLON study was approved by the Committee of Research involving Human Subjects (region Arnhem-Nijmegen), the Netherlands. All participants included in the study provided a written informed consent.